Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Compugen, an early stage drug and diagnostic discovery company, has appointed Martin Gerstel as its new president and CEO, effective January 1, 2009.
Subscribe to our email newsletter
Mr Gerstel, who has served as chairman of Compugen since 1997, will succeed current president and CEO Alex Kotzer, who recently informed the board of his interest to retire from his full time executive responsibilities. Mr Kotzer will remain a director of the company.
Prior to Mr Gerstel becoming chairman of Compugen, he was co-chairman and CEO of Alza, a California based pharmaceutical company which he helped found, and a member of the Pharmaceutical Research and Manufacturers of America.
Mr Kotzer said: “I am very pleased with Compugen’s progress and positioning for the future, and honored to remain on its board. I am sure that the transition of responsibilities to Martin will be seamless, and together with the company’s strong management team and talented employees, Compugen can leverage the progress achieved to date to lead the company to full commercial success.”